ATE40116T1 - 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva. - Google Patents

1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva.

Info

Publication number
ATE40116T1
ATE40116T1 AT83902866T AT83902866T ATE40116T1 AT E40116 T1 ATE40116 T1 AT E40116T1 AT 83902866 T AT83902866 T AT 83902866T AT 83902866 T AT83902866 T AT 83902866T AT E40116 T1 ATE40116 T1 AT E40116T1
Authority
AT
Austria
Prior art keywords
acyl
pyridylmethylguanidine
antihypertensives
guanidine
pyridylalkyl
Prior art date
Application number
AT83902866T
Other languages
English (en)
Inventor
William Lyon Studt
Harry Karl Zimmerman
Original Assignee
Rorer Int Overseas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer Int Overseas filed Critical Rorer Int Overseas
Application granted granted Critical
Publication of ATE40116T1 publication Critical patent/ATE40116T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT83902866T 1982-08-24 1983-08-23 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva. ATE40116T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/410,959 US4496573A (en) 1982-08-24 1982-08-24 1-Pyridylmethyl-3-acyl guanidines
PCT/US1983/001287 WO1984000963A1 (en) 1982-08-24 1983-08-23 1-acyl-3-pyridylguanidines and their use as antihypertensive agents
EP83902866A EP0116628B1 (de) 1982-08-24 1983-08-23 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva

Publications (1)

Publication Number Publication Date
ATE40116T1 true ATE40116T1 (de) 1989-02-15

Family

ID=23626973

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83902866T ATE40116T1 (de) 1982-08-24 1983-08-23 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva.

Country Status (7)

Country Link
US (1) US4496573A (de)
EP (1) EP0116628B1 (de)
JP (1) JPS59501715A (de)
AT (1) ATE40116T1 (de)
AU (1) AU1946983A (de)
DE (1) DE3378979D1 (de)
WO (1) WO1984000963A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371086A (en) * 1991-03-15 1994-12-06 The Green Cross Corporation Aminopyridine compounds
JPH05294935A (ja) * 1991-03-15 1993-11-09 Green Cross Corp:The アミノピリジン系化合物
EP2617709B8 (de) * 2003-06-26 2022-12-21 Biotron Limited Guanidinderivate als antivirale Agentien
US20070099968A1 (en) * 2004-06-26 2007-05-03 Biotron Limited Antiviral compounds and methods
WO2010124120A1 (en) 2009-04-22 2010-10-28 Mercator Medsystems, Inc. Use of guanethidine for treating hypertension by local vascular delivery
CN110200963A (zh) * 2011-10-19 2019-09-06 墨卡托医疗系统公司 局部调节组织和细胞以提高疗效包括肾去神经支配

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914306A (en) * 1972-09-22 1975-10-21 Rorer Inc William H Guanidines
GB1461806A (en) * 1974-03-05 1977-01-19 Wyeth John & Brother Ltd Pyridine derivatives
DE2728423A1 (de) * 1977-06-24 1979-01-04 Grote & Hartmann Federkabelschuh
US4287346A (en) * 1979-02-16 1981-09-01 Eisai Co., Ltd. Cyanoguanidine derivatives
US4246406A (en) * 1979-03-27 1981-01-20 Merck & Co., Inc. Heterocyclic substituted pyrazinoylguanidines

Also Published As

Publication number Publication date
US4496573A (en) 1985-01-29
WO1984000963A1 (en) 1984-03-15
EP0116628B1 (de) 1989-01-18
EP0116628A1 (de) 1984-08-29
JPS59501715A (ja) 1984-10-11
EP0116628A4 (de) 1985-02-18
AU1946983A (en) 1984-03-29
DE3378979D1 (en) 1989-02-23

Similar Documents

Publication Publication Date Title
TR199902124T2 (xx) �ltihapl� hastal�klar�n tedavisinde yararl� k���k molek�ller.
FI963070A0 (fi) Klooripyrimidiinivälituotteita
ATE234092T1 (de) 2-alkylpyrrolidine
ATE32730T1 (de) Indikatormarkierte konjugate von metallothionein und zielsuchenden, biologisch aktiven molekuelen.
TR200001312T2 (tr) Benzotiyazol protein tirozin kinaz önleyicileri.
ATE27457T1 (de) 1,2,4-triazine und pyrazin-derivate.
ES2152483T3 (es) Aplicacion terapeutica en anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de celulas b.
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
DK283881A (da) Fremgangsmaade til fremstilling af pyrazinyl1,2,4-oxadiazol-5-oner
DE69528710D1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
ES2139957T3 (es) Metodo para la determinacion del estado pretrombotico.
FR2491334B1 (de)
NO890046D0 (no) Disubstituerte pyridiner.
ATE40116T1 (de) 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva.
DE58906338D1 (de) Kombination von Angiotensin-Converting-Enzyme-Hemmern mit Kaliumkanal-Modulatoren sowie deren Verwendung in Arzneimitteln.
ATE39694T1 (de) (pyrrol-1-yl)-phenyl-dihydropyridazinone, ihre herstellung und verwendung.
ATE71149T1 (de) Monoklonale antikoerper.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ATE123942T1 (de) 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung als antikonvulsiva.
IT8420213A0 (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
IT1237088B (it) N,n'-di-(trimetossibenzoil) piperazine 2-carbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono.
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
ATE232738T1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties